© 2024 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
这家待售公司是一家位于印度班加罗尔的医疗保健公司。 该业务涉及为全球人民制造和供应药品和营养补充剂(符合 WHO-GMP 和 ISO 认证规定的质量标准)。
该业务设备齐全,符合 ISO 9001 和 WHO GMP 认证单位,可满足来自中美洲、尼日利亚、孟加拉国、柬埔寨、斯里兰卡、马来西亚、多米尼加共和国等国家的订单。该单位拥有超过 50000 平方英尺的建筑面积,专门用于 片剂、胶囊剂和口服液的生产。
公司生产仿制药、保健品和草药产品。
财务业绩亮点(3 年)
收入在过去 3 年稳步增长,但 EBITDA 有所下降。 EBITDA 的减少是由于 5 年前开始的在线品牌广告支出增加。 这个 D2C 补充剂品牌所获得的任何利润都被重新投入到该品牌的营销中,这导致了整个公司的 EBITDA 减少。
产品
438个仿制药生产许可证。 其中,公司目前持有 148 项 CoPP 批准,允许我们在多个 ROW 国家注册我们的产品出口。
综合竞争优势
具有成本优势的小规模制造设施的高生产能力。 位于班加罗尔市内的制造单位允许获得熟练和非熟练劳动力。
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
This website is operated by MergersUS Inc a US Corporation with registered office at
报错: 未找到这个表单
报错: 未找到这个表单
报错: 未找到这个表单
报错: 未找到这个表单
描述
这家待售公司是一家位于印度班加罗尔的医疗保健公司。 该业务涉及为全球人民制造和供应药品和营养补充剂(符合 WHO-GMP 和 ISO 认证规定的质量标准)。
该业务设备齐全,符合 ISO 9001 和 WHO GMP 认证单位,可满足来自中美洲、尼日利亚、孟加拉国、柬埔寨、斯里兰卡、马来西亚、多米尼加共和国等国家的订单。该单位拥有超过 50000 平方英尺的建筑面积,专门用于 片剂、胶囊剂和口服液的生产。
公司生产仿制药、保健品和草药产品。
财务业绩亮点(3 年)
收入在过去 3 年稳步增长,但 EBITDA 有所下降。 EBITDA 的减少是由于 5 年前开始的在线品牌广告支出增加。 这个 D2C 补充剂品牌所获得的任何利润都被重新投入到该品牌的营销中,这导致了整个公司的 EBITDA 减少。
产品
438个仿制药生产许可证。 其中,公司目前持有 148 项 CoPP 批准,允许我们在多个 ROW 国家注册我们的产品出口。
综合竞争优势
具有成本优势的小规模制造设施的高生产能力。 位于班加罗尔市内的制造单位允许获得熟练和非熟练劳动力。
Basic Details
Target Price:
$12,000,000
Gross Revenue
$1,900,000
EBITDA
TBA
Business ID:
L#20210016
Country
印度
City:
班加罗尔
详情
Similar Businesses
Published on 19 2 月, 2021 在 7:44 下午. 更新 16 3 月, 2023 在 5:21 下午
8.24 MW 太阳能发电厂,与政府签署 PPA
$9,500,000
制造业, 发电厂, 制造业, 发电厂
12000吨铝型材制造商
$6,000,000
制造业, 制造业
历史悠久的意大利啤酒品牌和制造业务 – “意大利制造”
TBD
制造业
著名足球俱乐部优质专利商品制造业务
$1,000,000
制造业, 制造业
意大利面食制造商业务“意大利制造”
TBD
制造业, 制造业
拥有30年历史的鸡肉加工制造企业
$575,000,000
制造业, 制造业
PREVIOUS PROPERTY
拥有 40 年历史的制药企业
NEXT PROPERTY
四星级豪华海滩酒店及赌场